Gene Doping

Genetic agonists are a practice of using gene therapy to improve athletic performance by changing the effectiveness of genes used for exercise. Gene agonists are defined as "non-therapeutic use of cells, genes, genetic elements or regulation of gene expression with the ability to improve exercise capacity" (light). Gene stimulating substances are considered very illegal in most sports, even if there are no known events that athletes use it. There are two types of gene doping, somatic gene doping and germline gene doping.

Gene agonists are products of gene therapy. However, gene doping is not an injection of DNA into the body to restore a specific function associated with damaged or deleted genes, but in gene therapy gene doping is a process of inserting DNA to enhance motor ability including. The World Anti-Doping Organization (WADA) was an international organization established in 1999, and in order to "promote, co-ordinate and supervise the fight against doping in all forms of sports", genetic stimulants are "on the cell" I have defined. Nontherapeutic use of genes, genes, or regulation of gene expression has the ability to improve performance "(World Anti-Doping Agency, 2008).

Today, the World Anti - Doping Organization has new obstacles to overcome, genetic stimulants. This practice is defined as non-therapeutic use of cells, genetics, or genetic elements to improve athletic performance. Genetic agonists use state-of-the-art research in gene therapy to transfer genetic material to human cells to treat or prevent disease (Well, 2008). As genetic stimulants usually increase the amount of proteins and hormones produced by cells, it is very difficult to test for genetic performance potentiators and new species to develop this form of stimulant Has been developed (Baoutina et al., 2008)

When considering the results of genetic studies, one of the first questions that arises when considering when and how it is used for genetic stimulants is whether genetic stimulants are "correct" is. Many people agree with WADA's view that genetic stimulants threaten the integrity of sporting events, but others have different opinions. For example, Julian Savulescu, Professor of Ethics at Oxford University in the UK, claims that "genetic enhancement does not infringe sportsmanship; it is sportsmanship" (Skipper, 2004). Whether or not DNA is used to improve athletic performance, it may be subject to intense debate over the next few years.